Eupraxia Pharmaceuticals is hosting a webinar on November 15, 2024, focusing on Eosinophilic Esophagitis, a rapidly growing digestive disorder. CEO Dr. James A. Helliwell will lead the discussion, ...
Discover the impact of hypereosinophilia on heart health, focusing on eosinophilic heart disease (EHD) and its mechanisms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback